Correlation Between OnKure Therapeutics, and Albertsons Companies

Can any of the company-specific risk be diversified away by investing in both OnKure Therapeutics, and Albertsons Companies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OnKure Therapeutics, and Albertsons Companies into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OnKure Therapeutics, and Albertsons Companies, you can compare the effects of market volatilities on OnKure Therapeutics, and Albertsons Companies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OnKure Therapeutics, with a short position of Albertsons Companies. Check out your portfolio center. Please also check ongoing floating volatility patterns of OnKure Therapeutics, and Albertsons Companies.

Diversification Opportunities for OnKure Therapeutics, and Albertsons Companies

-0.69

Correlation Coefficient

OnKure Therapeutics,  Albertsons Companies

Excellent diversification

The 3 months correlation between OnKure and Albertsons is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding OnKure Therapeutics, and Albertsons Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Albertsons Companies and OnKure Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OnKure Therapeutics, are associated (or correlated) with Albertsons Companies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Albertsons Companies has no effect on the direction of OnKure Therapeutics, i.e., OnKure Therapeutics, and Albertsons Companies go up and down completely randomly.

Pair Corralation between OnKure Therapeutics, and Albertsons Companies

Given the investment horizon of 90 days OnKure Therapeutics, is expected to generate 6.11 times more return on investment than Albertsons Companies. However, OnKure Therapeutics, is 6.11 times more volatile than Albertsons Companies. It trades about 0.01 of its potential returns per unit of risk. Albertsons Companies is currently generating about 0.0 per unit of risk. If you would invest  2,600  in OnKure Therapeutics, on October 4, 2024 and sell it today you would lose (1,748) from holding OnKure Therapeutics, or give up 67.23% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

OnKure Therapeutics,  vs.  Albertsons Companies

OnKure Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days OnKure Therapeutics, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in February 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Albertsons Companies

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Albertsons Companies are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite fairly unfluctuating fundamental indicators, Albertsons Companies may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Pair Trading with OnKure Therapeutics, and Albertsons Companies

The main advantage of trading using opposite OnKure Therapeutics, and Albertsons Companies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OnKure Therapeutics, position performs unexpectedly, Albertsons Companies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Albertsons Companies will offset losses from the drop in Albertsons Companies' long position.

The idea behind OnKure Therapeutics, and Albertsons Companies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.